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INTRODUCTION
For my cancer epidemiology research to flourish, the next phase of my training should include mentorship and training on the use of behavioral and biologic epidemiological methods concurrently. I seek to utilize this award to accomplish four main objectives: 1) To increase knowledge in and integrate the application of biologic and behavioral epidemiological methods in prostate cancer disparity research; 2) To increase my publication record; 3) To seek and obtain additional funding, specifically an R01, by the end of year four; 4) To strengthen skills in managing research teams and to develop relationship with colleagues who might serve as coinvestigators on future projects. The main goal of the project I am proposing for this career development award is to determine the impact vitamin D has on prostate-specific antigen (PSA) levels. We will be able to assess behaviors such as adherence to vitamin supplementation, diet and well as sun exposure. The future potential of this project is great. W e will be able to demonstrate in the highest risk group for prostate cancer, a tangible prevention strategy that is supported by sound epidemiology and has strong potential for dissemination.
BODY

Training Plan
Dr. Giovannucci, my mentor, has included me into his research team. In addition to guiding my research efforts, he has also been instrumental in making important connections for me within our field, allowing me to develop relationships with researchers that I otherwise would not. Currently, I am an Assistant Professor at Washington University in St. Louis; however, I maintain an active collaboration with Dr. Giovannucci and other investigators at Dana-Farber Cancer Institute and Harvard School of Public Health.
Dr. Giovannucci and I meet by phone on a regular basis to discuss methodological and analytical approaches, interpret outcomes, and outline manuscript ideas. We continue to work closely on the vitamin D supplementation project presented in this proposal. When we meet by phone we discuss the following topics: 1) Progress on manuscript and grant writing projects; 2) How my research is addressing prostate cancer disparities through biologic and behavioral approaches; 3) What is missing from my research program to address #2; 4) New research ideas. These discussions have resulted in an institutional award through the Nutrition Obesity Research Center at Washington University as well as the submission of an R03 on the prognostic effect of vitamin D on prostate cancer.
The objectives of this training award include: 1) To increase knowledge in and integrate the application of biologic and behavioral epidemiological methods in prostate cancer disparity research; 2) To increase my publication record; 3) To seek and obtain additional funding, specifically an R01 by the end of year four; 4) To strengthen skills in managing research teams and to develop relationship with colleagues who might serve as co-investigators on future projects.
Objective 1: This objective is being met through the conduct and participation in the research plan outlined below. Shortly, we will begin the analysis of this study which will allow me to delve further in to the application of behavioral and biological factors on prostate cancer disparities.
Objective 2: At the start of this award, I had a number of papers in progress. I have published 4 publications in the past year, one in the Journal of the American Medical Association. My paper-writing plan has shown to be effective. I have a number of papers currently in progress as well as several papers that will soon be in progress after the assays are conducted from the vitamin D supplementation trial. Data collection has recently ended for this study and data analysis will begin within the next 2-3 months.
Objective 3: Over the previous year, I have had numerous experiences in grant-writing and have also been successful in both federal and institutions grants. I plan to build on my currently funded research to apply for a Health Disparity Award through the PCRP at DOD in the summer of 2011. In addition to grant-writing experience, I had the opportunity to participate on an NIH review panel for R21 grants. This experience has positively impacted my approach to writing grants.
Objective 4: With my recently funded projects, I have the opportunity to hire and manage research assistants, study protocols and budgets. Through my collaborations with Dr. Giovannucci, as well as my current faculty appointment, I have established collaborations with other investigators and am currently collaborating on research projects, grant proposals and manuscripts.
Research
The research project proposed will examine differences in PSA levels associated with vitamin D intake (oral supplementation in three doses) and uptake (plasma measured 25(OH)D) among Black participants. PSA levels will be assessed, in men only (N=100), at baseline, 3-, and 6-month follow-up.
Our aims and hypotheses are as follows: Aim 1. To examine the influence of oral vitamin D supplementation on PSA levels. We will examine whether vitamin D supplementation is associated with plasma levels of PSA, and whether a threshold effect exists within this association. Hypothesis 1.1: Higher levels of vitamin D supplementation will be associated with lower PSA levels. Hypothesis 1.2: Vitamin D uptake (i.e. 25(OH)D levels) will be inversely associated with PSA levels.
The supplementation and follow-up periods for this study has recently completed. We are planning to analyze the blood-work within the next month. How current results are focused on recruitment and retention successes.
This study addresses the critical areas of cancer prevention and racial disparities by defining the optimal dose of vitamin D supplementation in Black men needed for future large intervention efforts in the prevention of prostate cancer. Study subjects were randomized to placebo, 1000IU, 2000IU, or 4000IU of vitamin D3 per day to determine the minimum dose of vitamin D needed to achieve an optimal level. Supplementation occurred during the winter months, to reduce sun exposure. After 3 months of supplementation, plasma levels of 25(OH)D and PSA levels are determined and compared to baseline levels. We also assessed vitamin D and PSA levels 3 months post supplementation
The recruitment goal was to enroll 320 participants, including 100 men, into the study. A 3-phase eligibility and consent process was used to reach this goal. 1. Only people who were AA, English-speaking, and 30-80 years old were approached to participate in the study. 2. Among these individuals, basic non-clinical eligibility criteria were assessed. 3. Primary care physicians of the remaining individuals were contacted to assess clinical eligibility. Targeted recruitment efforts focused on obtaining individuals who met the first phase eligibility criteria. Potential participants were identified at public housing sites, faith-based organizations, community organizations and through participant referrals. To encourage retention, a case-manager approach was implemented and research assistants made biweekly phone calls and monthly pill bottle exchange visits with participants.
Through our recruitment efforts, we consented 572 individuals and exceeded our recruitment goals with 329 participants enrolled in the study, including 107 men. During year 1, with 2.5 months of recruitment, we enrolled 46 participants. During years 2 and 3 with 6 months of recruitment each year, we enrolled 166, and 117 participants, respectively. Retention for the 3-and 6-month assessment was 90.54% and 89.13%, respectively.
Our strategies and lessons learned are relevant to other researchers conducting research in a population, such as this one, that has historically been challenging to recruit and retain into clinical studies.
Data anlaysis will begin in the next 2-3 months. We will examine the influence of 25(OH)D uptake on the difference between baseline, 3-month, and 6-month PSA levels as well as the difference between baseline and 6-month PSA level to assess if lack of significant change may be attributable to vitamin D supplementation. All analyses will be conducted first as intent-totreat and include all subjects, followed by analyses of only compliers. In the primary analysis, we will utilize the randomized trial structure to assess the association between vitamin D intake and PSA change. As a secondary analysis, we will assess the association between 25(OH)D uptake, categorized in tertiles ((below 32 ng/mL), acceptable (32 -40 ng/mL) and optimal (40 ng/mL and over)), and PSA change.
KEY RESEARCH ACCOMPLISHMENTS
Successful recruitment and retention of participants into the study. We met and slightly exceeded our recruitment efforts of 329 (320 proposed) participants of which 107 (100 proposed) were men. 
CONCLUSION
The proposed study will be among the first to examine the impact of vitamin D supplementation/uptake on PSA among Blacks in a non-patient sample. As a result of our work, we will learn more about the complicated biological relations between vitamin D and PSA. Additionally, this work will make an important contribution to our understanding of the role of vitamin D as a possible pathway for racial/ethnic prostate cancer disparities. We may derive preliminary public health messages regarding the association between vitamin D and these important cancer biomarkers. Further, it provides an excellent vehicle for the development of my skills in behavioral and social science, while continuing development of my expertise in epidemiology. The types of interventions that may evolve from my research program are prostate cancer prevention interventions targeting diet (vitamin D) consumption among the most at-risk groups. With the knowledge and experience gained from this award, I will make significant contributions to the development of effective studies that focus on the interactions between biologic and behavioral factors that contribute to prostate cancer disparities and how we can address the problem through a transdisciplinary approach to reduce the cancer burden.
There are many factors associated with vitamin D and its effects on prostate cancer. My future research will begin incorporating genetic polymorphisms within the vitamin D pathway as well as additional behavioral factors such as dietary intake and sun exposure behaviors that will provide a more complete representation of the mechanisms behind vitamin D effects.
Bettina Fisher Drake, MPH, PhD
SUMMARY:
My work focuses on the interactions between the social/behavioral and biological determinants of cancer disparities, an understanding of which may lead to the development of more effective disease prevention strategies. The objectives of my research program are: 1) to identify the modifiable and non-modifiable risk factors for cancer as well as the at-risk groups for these factors; 2) to utilize epidemiologic methods to understand the interactions between behavioral and biologic determinants of adverse cancer outcomes; 3) to contribute to the translation of epidemiological findings into behavioral interventions at the individual and population level. 
CITIZENSHIP:
